Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Cardiac experimental biology and translational research would benefit from an in vitro surrogate for human heart muscle. This study investigated structural and functional properties and interventional responses of human engineered cardiac tissues (hECTs) compared to human myocardium. Human embryonic stem cell‐derived cardiomyocytes (hESC‐CMs, >90% troponin‐positive) were mixed with collagen and cultured on force‐sensing elastomer devices. hECTs resembled trabecular muscle and beat spontaneously (1.18±0.48 Hz). Microstructural features and mRNA expression of cardiac‐specific genes ( α‐MHC, SERCA2a, and ACTC1 ) were comparable to human myocardium. Optical mapping revealed cardiac refractoriness with loss of 1:1 capture above 3 Hz, and cycle length dependence of the action potential duration, recapitulating key features of cardiac electrophysiology. hECTs reconstituted the Frank‐Starling mechanism, generating an average maximum twitch stress of 660 μN/mm 2 at L max , approaching values in newborn human myocardium. Dose‐response curves followed exponential pharmacodynamics models for calcium chloride (EC 50 1.8 mM) and verapamil (IC 50 0.61 μM); isoproterenol elicited a positive chronotropic but negligible inotropic response, suggesting sarcoplasmic reticulum immaturity. hECTs were amenable to gene transfer, demonstrated by successful transduction with Ad.GFP. Such 3‐D hECTs recapitulate an early developmental stage of human myocardium and promise to offer an alternative preclinical model for cardiology research.—Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J.‐J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., Hajjar, R. J., Hulot, J.‐S., Costa, K. D. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 28, 644–654 (2014). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but not pressure- and volume-based metrics directly representing pump performance of the heart”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, we have reported a linear relationship between the developed stress and axial stretch in hvCTS [14].”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The weak response is thought to be due to immature adrenergic and Ca2+ signaling pathways such as lowered phospholamban expression compared to their adult counterparts [14].”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Functionally, we observed an augmented sensitivity of the hvCOC to adrenergic stimulation and the presence of both chronotropic and inotropic effects when compared with the hvCTS and hvCMT systems constructed with the same hPSC-vCMs [14,18].”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the construction of tissues, specifically engineered 3D mimics, often necessitates the addition of stromal cells to facilitate proper formation of these tissue constructs.32,33”
From Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues (2023) · cites this paper as [32]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells
Xu, C., Police, S., Rao, N., & Carpenter, M. K. (2002) · Circulation Research · doi:10.1161/01.res.0000035254.80718.91 · Cited by 902 · cited 1×
“the response to pharmacologic agents (49), strategies”
Engler, A. J., Carag-Krieger, C., Johnson, C. P., Raab, M., Tang, H.-Y., Speicher, D. W., Sanger, J. W., Sanger, J. M., & Discher, D. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.029678 · Cited by 865 · cited 1×
“cardiomyocyte function and maturation (3, 4).”
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Luo, J., Deng, Z.-L., Luo, X., Tang, N., Song, W.-X., Chen, J., Sharff, K. A., Luu, H. H., Haydon, R. C., Kinzler, K. W., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.135 · Cited by 854
Feeder-independent culture of human embryonic stem cells
Ludwig, T. E., Bergendahl, V., Levenstein, M. E., Yu, J., Probasco, M. D., & Thomson, J. A. (2006) · Nature Methods · doi:10.1038/nmeth902 · Cited by 681 · cited 1×
“All experiments used cells derived from the HES2 hESC line (Wicell, Madison, WI, USA) propagated in feeder-free culture, as described previously (20).”
MethodGrowth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666 · cited 3×
“Since nonmyocytes can substantially affect cardiac cells (6, 16, 25, 26, 28), generation of human ECTs using well-defined cell populations is critical for studying the effects of heterocellular interactions on hECT viability, maturation, and function under controlled conditions.”
BackgroundMetabolic Gene Expression in Fetal and Failing Human Heart
Razeghi, P., Young, M. E., Alcorn, J. L., Moravec, C. S., Frazier, O. H., & Taegtmeyer, H. (2001) · Circulation · doi:10.1161/hc4901.100526 · Cited by 616 · cited 1×
“Interestingly, a 10 increase in ANF mRNA expression was also reported for human fetal heart compared to nonfailing adult heart mRNA (31).”
BackgroundZhang, D., Shadrin, I. Y., Lam, J., Xian, H.-Q., Snodgrass, H. R., & Bursac, N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.026 · Cited by 565 · cited 7×
“(9) showed that as hESC-CM purity increased from 48 to 90%, conduction velocity increased, while the contractile force per myocyte decreased, and other factors such as APD and maximum active force were not significantly affected by hESC-CM purity.”
BackgroundInfluentialTissue engineering of vascularized cardiac muscle from human embryonic stem cells
Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I. H. M., Gepstein, L., & Levenberg, S. (2007) · Circulation Research · doi:10.1161/01.res.0000257776.05673.ff · Cited by 558 · cited 1×
“Important advances have been made toward developing human engineered cardiac tissues (hECTs) as patches for myocardial repair, using biodegradable scaffolds (2, 8), fibrin-based hydrogels (9), or scaffoldfree constructs (10, 11).”
BackgroundDevelopment of a drug screening platform based on engineered heart tissue
Hansen, A., Eder, A., Bönstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schwörer, A., Uebeler, J., & Eschenhagen, T. (2010) · Circulation Research · doi:10.1161/circresaha.109.211458 · Cited by 510 · cited 1×
“We (22) and others (15, 32) have developed PDMS culture devices based on a simple beam-bending principle for optically monitoring forces generated by engineered tissues in a sterile, temperature-controlled environment.”
BackgroundFranz, M. R., Swerdlow, C. D., Liem, L. B., & Schaefer, J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113706 · Cited by 457 · cited 1×
“7C), comparable to measurements in human myocardium (48).”
BackgroundSubstrate Stiffness Affects the Functional Maturation of Neonatal Rat Ventricular Myocytes
Jacot, J. G., McCulloch, A. D., & Omens, J. H. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.124545 · Cited by 448 · cited 1×
“cardiomyocyte function and maturation (3, 4).”
Stevens, K. R., Kreutziger, K. L., Dupras, S. K., Korte, F. S., Regnier, M., Muskheli, V., Nourse, M. B., Bendixen, K., Reinecke, H., & Murry, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908381106 · Cited by 427 · cited 1×
“Important advances have been made toward developing human engineered cardiac tissues (hECTs) as patches for myocardial repair, using biodegradable scaffolds (2, 8), fibrin-based hydrogels (9), or scaffoldfree constructs (10, 11).”
BackgroundBoudou, T., Legant, W. R., Mu, A., Borochin, M. A., Thavandiran, N., Radisic, M., Zandstra, P. W., Epstein, J. A., Margulies, K. B., & Chen, C. S. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0341 · Cited by 413 · cited 1×
“We (22) and others (15, 32) have developed PDMS culture devices based on a simple beam-bending principle for optically monitoring forces generated by engineered tissues in a sterile, temperature-controlled environment.”
BackgroundNarmoneva, D. A., Vukmirovic, R., Davis, M. E., Kamm, R. D., & Lee, R. T. (2004) · Circulation · doi:10.1161/01.cir.0000140667.37070.07 · Cited by 366 · cited 1×
“Since nonmyocytes can substantially affect cardiac cells (6, 16, 25, 26, 28), generation of human ECTs using well-defined cell populations is critical for studying the effects of heterocellular interactions on hECT viability, maturation, and function under controlled conditions.”
BackgroundHuman engineered heart tissue as a versatile tool in basic research and preclinical toxicology
Schaaf, S., Shibamiya, A., Mewe, M., Eder, A., Stöhr, A., Hirt, M. N., Rau, T., Zimmermann, W.-H., Conradi, L., Eschenhagen, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026397 · Cited by 365 · cited 3×
“Eschenhagen and Zimmerman and colleagues, pioneers in the cardiac tissue engineering field (17), more recently published a study using hECTs created from human embryonic stem cells, demonstrating responses to proarrhythmic compounds similar to the industry standard hERG channel assay (18).”
BackgroundMechanisms Underlying Conduction Slowing and Arrhythmogenesis in Nonischemic Dilated Cardiomyopathy
Akar, F. G., Spragg, D. D., Tunin, R. S., Kass, D. A., & Tomaselli, G. F. (2004) · Circulation Research · doi:10.1161/01.res.0000144125.61927.1c · Cited by 309 · cited 1×
“Electrical functionality of the hECTs was tested using optical action potential (AP) mapping (23).”
MethodSelf-citationOptimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle
Naito, H., Melnychenko, I., Didié, M., Schneiderbanger, K., Schubert, P., Rosenkranz, S., Eschenhagen, T., & Zimmermann, W.-H. (2006) · Circulation · doi:10.1161/circulationaha.105.001560 · Cited by 301 · cited 1×
“Since nonmyocytes can substantially affect cardiac cells (6, 16, 25, 26, 28), generation of human ECTs using well-defined cell populations is critical for studying the effects of heterocellular interactions on hECT viability, maturation, and function under controlled conditions.”
BackgroundAge-related changes in beta-adrenergic neuroeffector systems in the human heart.
White, M., Roden, R., Minobe, W., Khan, M. F., Larrabee, P., Wollmering, M., Port, J. D., Anderson, F., Campbell, D., & Feldman, A. M. (1994) · Circulation · doi:10.1161/01.cir.90.3.1225 · Cited by 286 · cited 1×
“from older patients, with an EC50 value of 460 nM (47), implicating possible down-regulation and decreased”
BackgroundHolubarsch, C., Ruf, T., Goldstein, D. J., Ashton, R. C., Nickl, W., Pieske, B., Pioch, K., Lu¨demann, J., Wiesner, S., Hasenfuss, G., et al. (1996) · Circulation · doi:10.1161/01.cir.94.4.683 · Cited by 242
Transplantation of a Tissue-Engineered Human Vascularized Cardiac Muscle
Lesman, A., Habib, M., Caspi, O., Gepstein, A., Arbel, G., Levenberg, S., & Gepstein, L. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0130 · Cited by 241 · cited 1×
“Important advances have been made toward developing human engineered cardiac tissues (hECTs) as patches for myocardial repair, using biodegradable scaffolds (2, 8), fibrin-based hydrogels (9), or scaffoldfree constructs (10, 11).”
BackgroundPluripotent stem cell-derived cardiac tissue patch with advanced structure and function
Liau, B., Christoforou, N., Leong, K. W., & Bursac, N. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.050 · Cited by 233 · cited 2×
“Since nonmyocytes can substantially affect cardiac cells (6, 16, 25, 26, 28), generation of human ECTs using well-defined cell populations is critical for studying the effects of heterocellular interactions on hECT viability, maturation, and function under controlled conditions.”
BackgroundThree-dimensional biomaterials for the study of human pluripotent stem cells
Kraehenbuehl, T. P., Langer, R., & Ferreira, L. S. (2011) · Nature Methods · doi:10.1038/nmeth.1671 · Cited by 226 · cited 1×
“The tissue engineering field has also recognized the value of developing in vitro models for basic science, as well as drug discovery and toxicology screening applications (12, 13).”
BackgroundPeters, N. S., Severs, N. J., Rothery, S. M., Lincoln, C., Yacoub, M. H., & Green, C. R. (1994) · Circulation · doi:10.1161/01.cir.90.2.713 · Cited by 218 · cited 1×
“2C), similar to neonatal human heart tissue (29).”
BackgroundChang, M. G., Tung, L., Sekar, R. B., Chang, C. Y., Cysyk, J., Dong, P., Marbán, E., & Abraham, M. R. (2006) · Circulation · doi:10.1161/circulationaha.105.593038 · Cited by 216
Generation of Functional Ventricular Heart Muscle from Mouse Ventricular Progenitor Cells
Domian, I. J., Chiravuri, M., van der Meer, P., Feinberg, A. W., Shi, X., Shao, Y., Wu, S. M., Parker, K. K., & Chien, K. R. (2009) · Science · doi:10.1126/science.1177350 · Cited by 209
Kensah, G., Roa Lara, A., Dahlmann, J., Zweigerdt, R., Schwanke, K., Hegermann, J., Skvorc, D., Gawol, A., Azizian, A., Wagner, S., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs349 · Cited by 193 · cited 3×
“More recently, functional cardiac tissues have been created using purified human cardiomyocyte populations (9, 19), allowing the potential benefits of nonmyocytes to be systematically examined (9).”
BackgroundMethodRadisic, M., Park, H., Martens, T. P., Salazar‐Lazaro, J. E., Geng, W., Wang, Y., Langer, R., Freed, L. E., & Vunjak‐Novakovic, G. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31578 · Cited by 187
Gwathmey, J. K., Warren, S. E., Briggs, G. M., Copelas, L., Feldman, M. D., Phillips, P. J., Callahan, M., Schoen, F. J., Grossman, W., & Morgan, J. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115061 · Cited by 183 · cited 1×
“3* Compares to H (33, 36), I (37), M (33, 36) H (38) H (36), M (36), I (37) H (36), M (36) H (38), M (38)”
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
Peng, S., Lacerda, A. E., Kirsch, G. E., Brown, A. M., & Bruening-Wright, A. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.01.014 · Cited by 183 · cited 1×
“Despite these challenges, a growing understanding of the similarities between engineered and natural human myocardium remains encouraging, and the species dependence of cardiac drug responses (53, 54) argues strongly in favor of the continued development of model systems based on human cell sources, including hECTs cr…”
BackgroundKarakikes, I., Senyei, G. D., Hansen, J., Kong, C.-W., Azeloglu, E. U., Stillitano, F., Lieu, D. K., Wang, J., Ren, L., Hulot, J.-S., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0110 · Cited by 169
Self-citationScaffold-Free Human Cardiac Tissue Patch Created from Embryonic Stem Cells
Stevens, K. R., Pabon, L., Muskheli, V., & Murry, C. E. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0151 · Cited by 162 · cited 1×
“Important advances have been made toward developing human engineered cardiac tissues (hECTs) as patches for myocardial repair, using biodegradable scaffolds (2, 8), fibrin-based hydrogels (9), or scaffoldfree constructs (10, 11).”
BackgroundTiburcy, M., Didié, M., Boy, O., Christalla, P., Döker, S., Naito, H., Karikkineth, B. C., El-Armouche, A., Grimm, M., Nose, M., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.251843 · Cited by 139
Böhm, M., Morano, I., Pieske, B., Rüegg, J. C., Wankerl, M., Zimmermann, R., & Erdmann, E. (1991) · Circulation Research · doi:10.1161/01.res.68.3.689 · Cited by 138
Földes, G., Mioulane, M., Wright, J. S., Liu, A. Q., Novak, P., Merkely, B., Gorelik, J., Schneider, M. D., Ali, N. N., & Harding, S. E. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.029 · Cited by 127 · cited 1×
“development (1) and offer an important species-spe-”
Parthenogenetic stem cells for tissue-engineered heart repair
Didié, M., Christalla, P., Rubart, M., Muppala, V., Döker, S., Unsöld, B. W., El‐Armouche, A., Rau, T., Eschenhagen, T., Schwoerer, A. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66854 · Cited by 119 · cited 1×
“While gene expression of hECTs has been evaluated relative to age-matched embryoid bodies (18) and monolayer cultures (9), comparison to adult human myocardium has been limited (30).”
BackgroundLiu, J., Lieu, D. K., Siu, C. W., Fu, J.-D., Tse, H.-F., & Li, R. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00060.2009 · Cited by 109 · cited 1×
“The demonstrated efficacy of adenoviral-mediated gene transfer at various stages of hECT culture may be particularly relevant to such efforts, since temporally regulated gene expression can be used to facilitate maturation of hESC-CMs (50).”
BackgroundSelf-citationPhysiological aspects of cardiac tissue engineering
Eschenhagen, T., Eder, A., Vollert, I., & Hansen, A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00007.2012 · Cited by 100 · cited 1×
“Eschenhagen and Zimmerman and colleagues, pioneers in the cardiac tissue engineering field (17), more recently published a study using hECTs created from human embryonic stem cells, demonstrating responses to proarrhythmic compounds similar to the industry standard hERG channel assay (18).”
BackgroundSong, H., Yoon, C., Kattman, S. J., Dengler, J., Massé, S., Thavaratnam, T., Gewarges, M., Nanthakumar, K., Rubart, M., Keller, G. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905729106 · Cited by 93
Force Frequency Relationship of the Human Ventricle Increases During Early Postnatal Development
Wiegerinck, R. F., Cojoc, A., Zeidenweber, C. M., Ding, G., Shen, M., Joyner, R. W., Fernandez, J. D., Kanter, K. R., Kirshbom, P. M., Kogon, B. E., et al. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e318199093c · Cited by 86 · cited 4×
“The physiological muscle bath is widely used for testing contractile properties of cardiac tissue samples (33, 34) and provides an established basis for comparison of hECT twitch properties with a wealth of published data on human myocardium.”
BackgroundInfluentialRossman, E. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.001 · Cited by 84 · cited 3×
“The physiological muscle bath is widely used for testing contractile properties of cardiac tissue samples (33, 34) and provides an established basis for comparison of hECT twitch properties with a wealth of published data on human myocardium.”
BackgroundPillekamp, F., Haustein, M., Khalil, M., Emmelheinz, M., Nazzal, R., Adelmann, R., Nguemo, F., Rubenchyk, O., Pfannkuche, K., Matzkies, M., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0312 · Cited by 74 · cited 4×
“SR (37), consistent with the structurally immature SR”
ResultInfluentialSonnenblick, E. H., Ross, J., Covell, J. W., & D, E. B. M. (1966) · Circulation Research · doi:10.1161/01.res.19.5.980 · Cited by 68
Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy
Schwinger, R. H. G., Böhm, M., & Erdmann, E. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90755-k · Cited by 65 · cited 1×
“3* Compares to H (33, 36), I (37), M (33, 36) H (38) H (36), M (36), I (37) H (36), M (36) H (38), M (38)”
Nirmalanandhan, V. S., & Sittampalam, G. S. (2009) · SLAS Discovery · doi:10.1177/1087057109336591 · Cited by 65 · cited 1×
“The tissue engineering field has also recognized the value of developing in vitro models for basic science, as well as drug discovery and toxicology screening applications (12, 13).”
BackgroundReview of Cardiotoxicity in Pediatric Cancer Patients: During and after Therapy
Fulbright, J. M. (2011) · Cardiology Research and Practice · doi:10.4061/2011/942090 · Cited by 63 · cited 1×
“Meanwhile, as an in vitro model of immature human myocardium, hECTs may offer advantages for studying congenital heart diseases or for detecting acute cardiotoxicity of therapies for pediatric patients (51).”
In vitro and in vivo models for testing arrhythmogenesis in drugs
CARLSSON, L. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01590.x · Cited by 61 · cited 1×
“Even isolated natural heart preparations lack sensitivity to some known arrhythmogenic compounds (52), underscoring the challenges involved in designing model systems that can accurately identify promising new therapeutic agents.”
BackgroundMyocyte-Depleted Engineered Cardiac Tissues Support Therapeutic Potential of Mesenchymal Stem Cells
Serrao, G. W., Turnbull, I. C., Ancukiewicz, D., Kim, D. E., Kao, E., Cashman, T. J., Hadri, L., Hajjar, R. J., & Costa, K. D. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0278 · Cited by 54 · cited 3×
“We (22) and others (15, 32) have developed PDMS culture devices based on a simple beam-bending principle for optically monitoring forces generated by engineered tissues in a sterile, temperature-controlled environment.”
BackgroundMethodSelf-citationHasenfuss, G., Mulieri, L. A., Allen, P. D., Just, H., & Alpert, N. R. (1996) · Circulation · doi:10.1161/01.cir.94.12.3155 · Cited by 53 · cited 1×
“Compares to I (37) H (41), M (42) I (37) I (37) I (37)”
Diastolic dysfunction in hypertrophic cardiomyopathy.
Elliott, P. M., Brecker, S., & McKenna, W. J. (1998) · PubMed · Cited by 52
Cooper, I. C., & Fry, C. H. (1990) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(90)91479-q · Cited by 49 · cited 1×
“3*** Compares to H (39), M (40), I (37) H (39) H (39)”
Schwinger, R. H. G., Böhm, M., & Erdmann, E. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199006000-00006 · Cited by 47 · cited 2×
“inotropic response of human papillary muscles (40).”
Liang, H., Matzkies, M., Schunkert, H., Tang, M., Bonnemeier, H., Hescheler, J., & Reppel, M. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000303051 · Cited by 41 · cited 1×
“Despite these challenges, a growing understanding of the similarities between engineered and natural human myocardium remains encouraging, and the species dependence of cardiac drug responses (53, 54) argues strongly in favor of the continued development of model systems based on human cell sources, including hECTs cr…”
BackgroundHasenfuss, G., Mulieri, L. A., Leavitt, B. J., & Alpert, N. R. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1165 · Cited by 37 · cited 1×
“Compares to I (37) H (41), M (42) I (37) I (37) I (37)”
Calcium Preconditioning in Human Myocardium
Cain, B. S., Meldrum, D. R., Meng, X., Shames, B. D., Banerjee, A. M., & Harken, A. H. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00093-9 · Cited by 36 · cited 1×
“0 mM reported for adult human atrial trabeculae (44), the discrepancy may partly reflect known age-dependent differences in cardiac calcium sensitivity (45).”
BackgroundChanges in force and calcium sensitivity in the developing avian heart
Godt, R. E., Fogaça, R. T. H., & Nosek, T. M. (1991) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y91-251 · Cited by 33 · cited 1×
“0 mM reported for adult human atrial trabeculae (44), the discrepancy may partly reflect known age-dependent differences in cardiac calcium sensitivity (45).”
Background
Cited by
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 519
Ruan, J.-L., Tulloch, N. L., Razumova, M. V., Saiget, M., Muskheli, V., Pabon, L., Reinecke, H., Regnier, M., & Murry, C. E. (2016) · Circulation · doi:10.1161/circulationaha.114.014998 · Cited by 467
Marsano, A., Conficconi, C., Lemme, M., Occhetta, P., Gaudiello, E., Votta, E., Cerino, G., Redaelli, A., & Rasponi, M. (2016) · Lab on a Chip · doi:10.1039/c5lc01356a · Cited by 447
Shadrin, I. Y., Allen, B. W., Qian, Y., Jackman, C. P., Carlson, A. L., Juhas, M. E., & Bursac, N. (2017) · Nature Communications · doi:10.1038/s41467-017-01946-x · Cited by 420
Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models
Caddeo, S., Boffito, M., & Sartori, S. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00040 · Cited by 285
Metadata
- Authors
- Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., Hajjar, R. J., Hulot, J., & Costa, K. D.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Hong Kong (HK)
- Université Pierre-et-Marie-Curie (FR)
- Corresponding author
- Costa, Kevin D.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-10-30
- Volume
- 28
- Issue
- 2
- Pages
- 644-654
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3898643
- OpenAlex
- W2117852513
- Cited by
- 184
- References
- 55
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 13 · 2023: 13 · 2022: 10 · 2021: 17 · 2020: 13 · 2019: 17 · 2018: 13 · 2017: 16 · 2016: 26 · 2015: 24 · 2014: 11
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources
- National Center for Advancing Translational Sciences (UL1RR029887)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- engineered heart tissue, human embryonic stem cell-derived cardiomyocytes, Frank-Starling mechanism, cardiac electrophysiology, calcium chloride, verapamil, isoproterenol, gene transfer, collagen matrix, optical mapping, cardiac refractoriness, action potential duration
- MeSH terms
- Cell Line, Electrophysiology, Humans, Myocardium, Tissue Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.